益生菌衍生的两性外聚糖自组装辅助剂输送平台,用于增强免疫反应
Shouxin Sheng1, Haochi Zhang1, Xinyu Li1
1State Key Laboratory of Reproductive Regulation & Breeding of Grassland Livestock, School of Life Science, Inner Mongolia University, Hohhot, 010021, P.R. China.
Journal of nanobiotechnology
|May 19, 2024
概括
一种新型的外聚糖,NAPSL.p,作为一个自我辅助的纳米输送平台. 这种天然物质通过激活免疫路径和改善黑色素瘤和流感的抗原输送来提高疫苗的疗效.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 使用天然材料开发有效的疫苗输送系统来增强免疫反应是一个重大挑战.
- 现有的辅助剂往往有局限性,需要探索新的,可生物降解的替代品.
研究的目的:
- 引入NAPSL.p,一种天然的两式外聚糖,作为一种具有免疫辅助性质的自组装纳米输送平台.
- 评估NAPSL.p作为纳米疫苗配方中辅助剂的疗效,以增强对癌症和传染病的免疫反应.
主要方法:
- NAPSL.p以其自我组装特性而闻名,并被用来形成一个纳米疫苗,使用卵胺 (OVA) 作为模型抗原.
- 在接种疫苗的小鼠中评估了免疫细胞吸收,体内药理动力学和幽默/细胞免疫反应.
- 对B16-OVA黑色素瘤外移植的治疗疗效和对流感的保护作用与传统辅助剂进行了比较.
主要成果:
- NAPSL.p显示出了显著的自我组装,形成了同质的纳米疫苗,并显著增加了树突细胞的抗原吸收.
- 在体内研究显示,抗原的药理动力学延长,特定IgG标位升高,黑色素瘤瘤的排斥增强.
- 与氧化相比,NAPSL.p疫苗引发了强大的CD4+和CD8+T细胞反应,并提供了比氧化更好的抗流感保护.
结论:
- NAPSL.p 作为一个强大的,自然的自我辅助的输送平台,激活了托尔类受体4 (TLR4) 途径.
- 这种纳米疫苗平台显示出在预防和治疗黑色素瘤和流感等传染病方面提高疫苗疗效的巨大潜力.
- NAPSL.p代表了一个有希望的可生物降解的替代品,用于下一代疫苗的开发,跨越多种应用.
更多相关视频
相关概念视频
Vaccinations
Overview
Oligosaccharide Assembly
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Formation of Lipopolysaccharides
Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...


